Kiniksa Pharmaceuticals International (KNSA) Net Margin Growth (1y) (2022 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Net Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.14 Bn | 5.61 Bn | 220.03 Mn | -93.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -93.00 |
| Mar 31, 2026 | 435.00 |
| Dec 31, 2025 | 1,428.00 |
| Sep 30, 2025 | 2,150.00 |
| Jun 30, 2025 | 1,497.00 |
| Mar 31, 2025 | 2,837.00 |
| Dec 31, 2024 | 5,180.00 |
| Sep 30, 2024 | 935.00 |
| Jun 30, 2024 | -2,455.00 |
| Mar 31, 2024 | 321.00 |
| Dec 31, 2023 | 65.00 |
| Sep 30, 2023 | -24,671.00 |
| Jun 30, 2023 | 9,503.00 |
| Mar 31, 2023 | 5,294.00 |
| Dec 31, 2022 | 17,545.00 |
| Sep 30, 2022 | 47,858.00 |
| Jun 30, 2022 | 46,542.00 |